Cytovance Biologics has completed an FDA inspection that took place July 11, 2017 at its Oklahoma City facilities. The eight-day inspection focused on Quality Systems. Overall the inspection was positive and the inspector acknowledged that the site had already identified and taken action on most of the four observations.   Specifically, Cytovance had taken action to address the facility improvements. All the facility updates are scheduled to be completed during Cytovance’s end of summer shutdo...